36 min listen
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
Gene Tx For Hearing Loss with Sensorion's Nawal Ouzren
ratings:
Length:
54 minutes
Released:
Apr 17, 2023
Format:
Podcast episode
Description
We often talk about biotechs taking "big swings." This week's guest is swinging for the fences with a lineup of gene therapies designed to address multiple forms of hearing loss, which affect multiple millions (if not, billions) of people worldwide. Adding to the challenge she's accepted, Sensorion CEO Nawal Ouzren is architecting an approach that seeks to restore hearing that's been lost due to genetic factors, treat sudden hearing disorders, and proactively prevent hearing loss due to common causes such as cisplatin induced ototoxicity or cochlear implantation. Listen in as Ouzren shares her holistic and aggressive plans with the Business of Biotech. Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!
Released:
Apr 17, 2023
Format:
Podcast episode
Titles in the series (100)
005: Building A Biotech All-Star Team With Vivek Ramaswamy by Business Of Biotech